Discontinuation report PHENYTOIN SODIUM
Report ID | 60687 |
Drug Identification Number | 02460912 |
Brand name | APO-PHENYTOIN SODIUM |
Common or Proper name | PHENYTOIN |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | PHENYTOIN SODIUM |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | N03AB |
ATC description | ANTIEPILEPTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2018-10-29 |
Remaining supply date | 2018-10-29 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-09-08 | English | Compare |
v2 | 2018-09-08 | French | Compare |
v3 | 2018-12-28 | English | Compare |
v4 | 2018-12-28 | French | Compare |
Showing 1 to 4 of 4